Laboratory Chemicals Market Report 2026

The laboratory chemicals market size has grown strongly in recent years. It will grow from $4.28 billion in 2025 to $4.58 billion in 2026 at a compound annual growth rate (CAGR) of 7%. The growth in the historic period can be attributed to expansion of pharmaceutical research activities, growth of academic research funding, increasing diagnostic testing volumes, rising environmental monitoring programs, availability of advanced analytical techniques.

The laboratory chemicals market size is expected to see strong growth in the next few years. It will grow to $6.14 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing investments in biotechnology research, rising demand for personalized medicine research inputs, expansion of genomics and proteomics studies, growing outsourcing of laboratory testing services, increasing focus on sustainable chemical formulations. Major trends in the forecast period include increasing demand for high-purity research chemicals, rising adoption of ready-to-use reagents, growing use of cell and molecular biology consumables, expansion of environmental testing reagents, enhanced focus on standardized laboratory protocols.

The increasing clinical research activities are expected to drive the growth of the laboratory chemicals market in the coming years. Clinical research involves studies with human participants to evaluate the safety and effectiveness of new medical treatments, interventions, or diagnostic procedures. Laboratories supporting clinical research utilize laboratory chemicals to conduct routine and specialized assays, employing methodologies such as tandem mass spectrometry, fully automated devices, and high-performance liquid chromatography. For example, in 2023, the UK Office for National Statistics reported that government spending on research and development (R&D) rose to £17.4 billion ($22.1 billion), up from £16.1 billion ($20.45 billion) in 2022, marking an 8.2% increase. Therefore, the growth of clinical research activities is supporting the laboratory chemicals market.

Leading companies in the laboratory chemicals market are developing detection solutions, such as in vitro diagnostics (IVD) kits, to enhance laboratory diagnostics and maintain a competitive edge. IVD kits are tests conducted on samples, including blood or tissue, outside the body to detect diseases or conditions. For instance, in October 2023, Alfa Chemistry, a US-based contract research organization (CRO), launched several IVD products, including the COVID-19 Mutation RT-qPCR Detection Kit, COVID-19 RT-qPCR Detection Kit Plus, and COVID-19 RT-qPCR Detection Kit (RUO), to meet the growing demand for reliable diagnostic tools. The COVID-19 Mutation RT-qPCR Detection Kit identifies Alpha, Delta, and Kappa variants of SARS-CoV-2, supporting pandemic control efforts. The COVID-19 RT-qPCR Detection Kit Plus provides rapid and accurate detection of SARS-CoV-2 with high sensitivity and specificity, while the COVID-19 RT-qPCR Detection Kit RUO is designed for human respiratory tract specimens, delivering results in under two hours.

In December 2023, Danaher Corporation, a US-based science and technology company, acquired Abcam plc for an undisclosed amount. This acquisition strengthens Danaher’s position in the life sciences and diagnostics sector by expanding its portfolio of research tools, accelerating innovation in proteomics and antibody development, broadening customer reach across biopharma and academic research, and supporting long-term growth in biologics and precision medicine. Abcam plc, based in the UK, supplies research-grade antibodies, reagents, and tools for drug discovery, diagnostics, and scientific research.

Major companies operating in the laboratory chemicals market are Merck KGaA, Thermo Fisher Scientific Inc., Avantor, Inc., Sigma-Aldrich Corporation, Lonza Group AG, TCI Chemicals (India) Pvt. Ltd., Tokyo Chemical Industry Co., Ltd., Honeywell International Inc., Spectrum Chemical Manufacturing Corp., Alfa Aesar, VWR International, LLC, MP Biomedicals, LLC, Bio-Rad Laboratories, Inc., Roche Diagnostics International Ltd., Agilent Technologies, Inc., PerkinElmer, Inc., GE Healthcare Life Sciences, Promega Corporation, HiMedia Laboratories Pvt. Ltd., Sisco Research Laboratories Pvt. Ltd.

Europe was the largest region in the laboratory chemicals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the laboratory chemicals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the laboratory chemicals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The laboratory chemicals market consists of sales of reagents, acids, bases, flammable liquids, toxic chemicals, buffers and surfactants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.